Alfacalcidol Stada 1 micrograme capsule moi, Yorvipath 168 micrograms/0.56 mL solution for injection in pre‑filled pen clinical trials

Impact of treatment with TransCon PTH on Quality of Life, cognitive function, brain structure, and cerebral capillary bloodflow in patients with hypoparathyroidism

This study looks at how a new treatment for hypoparathyroidism, called Yorvipath, affects memory, brain health, and blood flow in the brain. It compares it to standard treatments to see if it improves how people feel and think.